메뉴 건너뛰기




Volumn 21, Issue 8, 2009, Pages 1255-1268

Targeting EGFR resistance networks in head and neck cancer

Author keywords

EGFR; Epidermal growth factor receptor; Head and neck cancer; Resistance pathways; SCCHN; Signaling

Indexed keywords

ADAM PROTEIN; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; EVEROLIMUS; FLUOROURACIL; GEFITINIB; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PERTUZUMAB; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLACEBO; PLATINOID; PROTEIN INHIBITOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE INHIBITOR; SCATTER FACTOR RECEPTOR; SCATTER FACTOR RECEPTOR INHIBITOR; SOMATOMEDIN; STAT PROTEIN; STEROID RECEPTOR COACTIVATOR INHIBITOR; SUNITINIB; TRASTUZUMAB; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

EID: 67349204371     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2009.02.021     Document Type: Review
Times cited : (70)

References (236)
  • 15
    • 45349096041 scopus 로고    scopus 로고
    • http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf. Cancer Facts and Figures 2008: American Cancer Society.
    • (2008) Cancer Facts and Figures


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.